Education Sessions: Monday, 4 June 2012
Choose one morning session and one afternoon session
Morning Session
11.00 - 12.15
Choose One |
1A: Benefits of PAI Readiness and Data Integrity for
Speedy Approvals
Moderator: J. David Doleski, Supervisory Consumer Safety Officer, DMPQ, CDER, FDA, USA
View Session Speakers
|
1B: Why It Pays to Continually Reinvest in Your
Facilities & Systems
Moderator: Steven Lynn, Office Director (acting), Office of Manufacturing and Product Quality, Office of
Compliance, CDER, FDA
View Session
Speakers
|
Afternoon Session
14.00 – 15.30
Choose One |
2A: Regulatory Success in a Cloud
Environment
Moderator: Randy Perez, Director, Information Governance and Management, Novartis, USA
View Session
Speakers
|
2B: Sustaining Compliance Consistency throughout Your
Supplier Networks
Moderator: Michael Arnold, R.Ph., Senior Director, Strategic Partnerships, Pfizer Global Clinical
Supplies, USA
View Session
Speakers
|
| 16.00 – 17.00 |
Forum 1: Industry-Led
Hot Topic Discussion Forum
Industry leaders will facilitate a group discussion to identify critical industry issues, concerns, needs
for clarity, and opportunities for collaboration.
Moderator: Brian Lange, P.E., Operations Director- Merck Manufacturing Division, North American Operations
and Consumer Care, Merck, USA
|
Education Sessions: Tuesday, 5 June 2012
Choose one morning session and one afternoon session
Morning Session
11.00 – 12.30
Choose One |
3A: Watching Your Process – Assuring Quality in Process
Performance
Moderator: Joe Famulare, Senior Director, Genentech, USA
View Session
Speakers
|
3B: Quality Risk Management: Using Risk Assessments in
Manufacturing
Moderator: Michael Smedley, Supervisory Consumer Safety Officer, CDER, FDA, USA
View Session Speakers
|
Afternoon Session
15.15 – 17.00
Choose One |
4A: Flexible Manufacturing
Moderator: Jim Breen, Vice President Project Management, Johnson & Johnson, USA
View Session Speakers
|
4B: CAPA Case Studies
Moderator: Rick Friedman, Associate Director for Risk-Science Intelligence and Prioritization, OMPQ, OC,
CDER, FDA, USA
View Session Speakers
|
| 13.30 – 14.30 |
Forum 2: Meet the
Press
Mixed panel of regulators and industry answering today’s most pressing questions.
|